Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure.

Salvatore Di Somma1, Laura Magrini, Marinella Mazzone

  • 1Emergency Medicine Department, II Medical School University La Sapienza, Sant'Andrea Hospital, 00189 Rome, Italy. salvatore.disomma@uniroma1.it

The American Journal of Emergency Medicine
|March 14, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D at hospital admission as an independent predictor of outcome of sepsis patients: Results of a secondary analysis from a "Need-Speed" trial prospective cohort.

European journal of internal medicine·2026
Same author

Is an ED discharge safe after a single cardiac troponin: Analysis of the FAST-TRAC study.

The American journal of emergency medicine·2026
Same author

Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI).

Kidney medicine·2026
Same author

Patient-reported health status and mortality across heart failure phenotypes: The modifying role of atrial fibrillation.

Kardiologia polska·2026
Same author

Identification of Parathyroid Glands Through Near-Infrared Autofluorescence During Thyroid Surgery: Retrospective Analysis of the Impact on Post-Operative Hypocalcemia Rate Reduction and Potential Improvement of Healthcare Expenditure.

Medicina (Kaunas, Lithuania)·2025
Same author

Value of cDPP3 as a short-term prognostic biomarker in all-comers critically ill patients in the emergency department.

Critical care (London, England)·2025
This summary is machine-generated.

Sequential plasma amino-terminal pro-B-type natriuretic peptide (NTproBNP) measurements effectively track acute decompensated heart failure (ADHF) symptom improvement. A significant NTproBNP decrease by discharge indicates successful treatment and clinical recovery in ADHF patients.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Emergency Medicine

Background:

  • Acute decompensated heart failure (ADHF) presents with acute dyspnea, necessitating prompt diagnosis and management.
  • Amino-terminal pro-B-type natriuretic peptide (NTproBNP) is a key biomarker in heart failure assessment.
  • Serial monitoring of biomarkers can provide insights into treatment efficacy.

Purpose of the Study:

  • To investigate the utility of serial plasma NTproBNP measurements in monitoring treatment response in ADHF patients.
  • To compare NTproBNP level variations in ADHF patients versus control groups with similar symptoms.
  • To establish the correlation between NTproBNP reduction and clinical improvement in ADHF.

Main Methods:

  • Investigated 37 consecutive ADHF patients presenting with acute dyspnea.

Related Experiment Videos

  • Included control groups: 10 with chronic obstructive pulmonary disease exacerbation and 10 with hypertension crisis.
  • Measured plasma NTproBNP levels at admission, 4, 12, 24 hours, and on discharge day for all participants.
  • Main Results:

    • ADHF patients showed a 58% reduction in plasma NTproBNP levels by discharge, correlating with symptom relief.
    • Clinical improvement in ADHF patients was associated with enhanced physiologic parameters and New York Heart Association functional class.
    • Control groups (COPD and hypertension crisis) exhibited no significant NTproBNP variations throughout the study period.

    Conclusions:

    • Sequential NTproBNP measurements provide a valuable plasma profile for assessing ADHF treatment response.
    • A significant decrease in NTproBNP levels is strongly associated with clinical improvement and successful discharge in ADHF patients.
    • NTproBNP serves as a reliable indicator for monitoring therapeutic outcomes in acute decompensated heart failure.